Evidence map›Paper›PMID 25288153›Full record

ArticleMolecular neurobiology2015

Stress Conditions Increase Vimentin Cleavage by Omi/HtrA2 Protease in Human Primary Neurons and Differentiated Neuroblastoma Cells.

Bérangère Lucotte, Mehdi Tajhizi, Dareen Alkhatib, Eva-Britt Samuelsson, Birgitta Wiehager, Sophia Schedin-Weiss, Erik Sundström, Bengt Winblad, Lars O Tjernberg, Homira Behbahani

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Non-Canonical Roles of Apoptotic Caspases in the Nervous System.Frontiers in cell and developmental biology · 2022
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Bérangère LucotteKarolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Center for Alzheimer Research, Division for Neurogeriatrics, Novum 5th floor, SE-141 57, Huddinge, Sweden.
Mehdi TajhiziKarolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Center for Alzheimer Research, Division for Neurogeriatrics, Novum 5th floor, SE-141 57, Huddinge, Sweden.
Dareen AlkhatibKarolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Center for Alzheimer Research, Division for Neurogeriatrics, Novum 5th floor, SE-141 57, Huddinge, Sweden.
Eva-Britt SamuelssonKarolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Center for Alzheimer Research, Division for Neurogeriatrics, Novum 5th floor, SE-141 57, Huddinge, Sweden.
Birgitta WiehagerKarolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Center for Alzheimer Research, Division for Neurogeriatrics, Novum 5th floor, SE-141 57, Huddinge, Sweden.
Sophia Schedin-WeissKarolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Center for Alzheimer Research, Division for Neurogeriatrics, Novum 5th floor, SE-141 57, Huddinge, Sweden.
Erik SundströmKarolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Center for Alzheimer Research, Division for Neurogeriatrics, Novum 5th floor, SE-141 57, Huddinge, Sweden.
Bengt WinbladKarolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Center for Alzheimer Research, Division for Neurogeriatrics, Novum 5th floor, SE-141 57, Huddinge, Sweden.
Lars O TjernbergKarolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Center for Alzheimer Research, Division for Neurogeriatrics, Novum 5th floor, SE-141 57, Huddinge, Sweden.
Homira BehbahaniKarolinska Institutet, Department of Neurobiology, Care Sciences and Society (NVS), Center for Alzheimer Research, Division for Neurogeriatrics, Novum 5th floor, SE-141 57, Huddinge, Sweden. homira.behbahani@ki.se.
Karolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysfunctional Omi/HtrA2, a mitochondrial serine protease, has been implicated in various neurodegenerative disorders. Despite the wealth of evidence on the roles of Omi/HtrA2 in apoptosis, little is known about its cytosolic targets, the cleavage of which could account for the observed morphological changes such as cytoskeletal reorganizations in axons. By proteomic analysis, vimentin was identified as a substrate for Omi/HtrA2 and we have reported increased Omi/HtrA2 protease activity in Alzheimer disease (AD) brain. Here, we investigated a possible link between Omi/HtrA2 and vimentin cleavage, and consequence of this cleavage on mitochondrial distribution in neurons. In vitro protease assays showed vimentin to be cleaved by Omi/HtrA2 protease, and proximity ligation assay demonstrated an increased interaction between Omi/HtrA2 and vimentin in human primary neurons upon stress stimuli. Using differentiated neuroblastoma SH-SY5Y cells, we showed that Omi/HtrA2 under several different stress conditions induces cleavage of vimentin in wild-type as well as SH-SY5Y cells transfected with amyloid precursor protein with the Alzheimer disease-associated Swedish mutation. After stress treatment, inhibition of Omi/HtrA2 protease activity by the Omi/HtrA2 specific inhibitor, Ucf-101, reduced the cleavage of vimentin in wild-type cells. Following altered vimentin filaments integrity by stress stimuli, mitochondria was redistributed in differentiated SH-SY5Y cells and human primary neurons. In summary, the findings outlined in this paper suggest a role of Omi/HtrA2 in modulation of vimentin filamentous structure in neurons. Our results provide important findings for understanding the biological role of Omi/HtrA2 activity during stress conditions, and give knowledge of interplay between Omi/HtrA2 and vimentin which might affect mitochondrial distribution in neurons.

Indexed as

Amyloid beta-Protein PrecursorAxonsCell Line, TumorCulture Media, Serum-FreeCytosolHigh-Temperature Requirement A Serine Peptidase 2HumansInterleukin-1betaIntermediate FilamentsIsothiocyanatesMitochondriaMitochondrial ProteinsMutation, MissenseNeoplasm ProteinsNerve Tissue ProteinsNeuroblastomaAmyloid beta-Protein PrecursorCulture Media, Serum-FreeHigh-Temperature Requirement A Serine Peptidase 2HTRA2 protein, humanInterleukin-1betaIsothiocyanatesMitochondrial ProteinsNeoplasm ProteinsNerve Tissue ProteinsPyrimidinonesSerine EndopeptidasesSerine Proteinase InhibitorssulforaphaneSulfoxidesThionesTretinoinTunicamycinUCF 101VimentinAlzheimer diseaseAPPsweHuman primary neuronsMitochondriaOmi/HtrA2Vimentin

Identifiers

PMID25288153
OpenAlexW2017026565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.